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Measles virus (MV) infects dendritic cells (DCs) resulting in immunosuppression. Human DCs express two MV receptors: CD46 and
human signaling lymphocyte activation molecule (hSLAM); thus, the role played by either alone is unclear. Because wild-type (wt) MV uses
hSLAM receptor preferentially, we dissected the molecular basis of MV–DC interaction and resultant immunosuppression through the
hSLAM receptor by creating transgenic (tg) mice expressing hSLAM on DCs. After infection with wt MV, murine splenic DCs expressing
hSLAM receptor had less B7-1, B7-2, CD40, MHC class I, and MHC class II molecules on their surfaces and displayed an increased rate of
apoptosis when compared to uninfected DCs. Further, MV-infected DCs failed to stimulate allogeneic T cells and inhibited mitogen-
dependent T-cell proliferation. Individual expression of human SLAM, interferon a/h receptor, tumor necrosis factor-a, and lymphotoxin-a
or h from T cells was not required for MV-infected DCs to inhibit the proliferation of T cells.
D 2004 Elsevier Inc. All rights reserved.Keywords: Measles virus; Dendritic cells; Transgenic mice; Immunosuppression; SLAM; Lymphocyte proliferationIntroduction
Measles virus (MV) is a contagious human pathogen that
continues to infect 30–40million humans annually leading to
approximately 1 million deaths despite the availability of an
effective attenuated vaccine (The World Health Report,
2002). MV infects cells of the immune system and induces
a transient but profound suppression of immune responses,
which is the major cause of related fatalities (Griffin, 1995;
McChesney and Oldstone, 1989). How MV impairs immu-
nity has been extensively studied and likely involves multiple
mechanisms. T lymphocytes are permissive to MV infection
(Hyypia et al., 1985; Joseph et al., 1975; Sullivan et al., 1975)
leading subsequently to an inhibition of their proliferative
responses to mitogens, alloantigens, and recalled antigens
(McChesney et al., 1988; Naniche et al., 1999; Sun et al.,
1998).WhenMVinfects antigen-presenting cells (APC) such0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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modulation of cross-talk between T cells and APC, thereby
aborting the induction of adaptive immune responses
(Schneider-Schaulies et al., 2003; Servet-Delprat et al.,
2003). Human DCs obtained from cultures of blood CD34+
cells, monocytes, and Langerhans cells are susceptible to MV
infection in vitro (Dubois et al., 2001; Fugier-Vivier et al.,
1997; Grosjean et al., 1997; Schnorr et al., 1997; Servet-
Delprat et al., 2000a, 2000b). Such infection enhances
apoptosis of DCs and inhibits CD40 ligand-dependent ter-
minal differentiation of DCs. Additionally, cocultivation of
MV-infected DCs with T cells increases Fas-mediated DC
apoptosis as well as virus production. MV-infected DCs also
upregulate their expression of TRAIL (Vidalain et al., 2000)
and inhibit proliferation of naive and activated T cells.
Human DCs express the two known receptors for MV:
CD46 and human signaling lymphocyte activation molecule
(hSLAM) (Dorig et al., 1993; Erlenhoefer et al., 2001; Hsu
et al., 2001; Manchester et al., 1994; Naniche et al., 1993;
Tatsuo et al., 2000). Human complement regulatory protein
(CD46) is constitutively expressed on all nucleated cells
(McQuaid and Cosby, 2002), and transgenic (tg) mice
expressing the human CD46 receptor have been generated
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neurons and cells of the immune system (Horvat et al.,
1996; Lawrence et al., 1999; Oldstone et al., 1999; Patterson
et al., 2002; Rall et al., 1997; Slifka et al., 2003; Yannoutsos
et al., 1996). However, wild-type (wt) MV or MV passaged
on B95-8 cells does not use the CD46 receptor for entry into
cells as efficiently as MV vaccine strains do. That is, the
interaction of wt MV with CD46 is weaker than its inter-
action with hSLAM (Erlenhofer et al., 2002; Manchester et
al., 2000; Ono et al., 2001a; Schneider et al., 2002). SLAM
is a prototypic receptor belonging to a SLAM subfamily
within the CD2 immunoglobulin superfamily and facilitates
modulation of lymphocyte proliferation and cytokine pro-
duction (Cocks et al., 1995; Veillette and Latour, 2003).
SLAM family receptors mediate intracellular protein tyro-
sine phosphorylation signals dependent on the binding
affinity to SLAM-associated protein (SAP) or EAT-2 (Chan
et al., 2003; Engel et al., 2003). The expression of SLAM is
restricted to immune-system cells such as immature thymo-
cytes, memory T cells, activated T cells, B cells, monocytes,
and DCs (Cocks et al., 1995; McQuaid and Cosby, 2002;
Minagawa et al., 2001; Murabayashi et al., 2002; Punnonen
et al., 1997; Sidorenko and Clark, 1993). MV binds to the V
domain of hSLAM but does not bind to the mouse coun-
terpart indicating that murine SLAM does not serve as a
cellular receptor for MV (Ohno et al., 2003; Ono et al.,
2001b).
Despite numerous studies performed in vitro, the mech-
anism of immunosuppression caused by MV infection ofFig. 1. Tg construct of CD11c-hSLAM fusion gene and analysis of hSLAM protein
CD11c-hSLAM tg mice. Briefly, hSLAM cDNA (black box) was introduced into
and h-Globin cassette (striped box). (B) hSLAM expression on several cell type
CD11b, CD4, CD8, B220, or NK1.1 molecules combined with an antibody to hSL
tg mice (open histogram) or non-tg mice (filled histogram). Panel (C) illustrates th
GM-CSF. At day 0, 3, 6, and 9 after culturing BM cells from non-tg (upper panels)
in each graph.human DCs remains obscure primarily because DCs simul-
taneously express the two MV receptors CD46 and SLAM,
whose activities are, so far, inseparable. To address this
issue and focus directly on MV interaction with SLAM on
DCs, we created tg mice whose DCs expressed hSLAM by
using the CD11c promoter. We report here that CD11c+ DCs
from tg mice expressed hSLAM protein and were permis-
sive to MV, whereas DCs from non-tg mice had neither
property. With this model, we showed that DCs infected
with MV via hSLAM were deficient in stimulating alloge-
neic T cells in a mixed lymphocyte reaction (MLR) and
causing naive T cells to proliferate in the presence of
mitogens. These events were associated with MV-induced
downregulation of MHC class I and II and B7-1, B7-2, and
CD40 co-activation molecules on DCs, as well as enhanced
apoptosis of DCs.Results
Generation of tg mice expressing hSLAM on DCs
To express hSLAM on murine DCs, we created tg mice
with hSLAM transcriptionally regulated by the CD11c
promoter (Fig. 1A). Single cell suspensions from spleens
of CD11c-hSLAM tg and non-tg mice were analyzed by
flow cytometry for hSLAM protein expression on diverse
immune cells. As shown in Fig. 1B, hSLAM protein was
expressed on the surface of splenic CD11c+ DCs, but not onexpression. Panel (A) represents the fusion gene construct used to generate
an EcoRI-treated pCD11c vector, between the CD11c promoter (open box)
s from tg mice. Splenocytes were stained with antibody to mouse CD11c,
AM. Histograms represent the expression of hSLAM on specific cells from
e generation of CD11c+ hSLAM+ cells from BM cultures in the presence of
or tg mice (lower panels), CD11c+ hSLAM+ cells are shown as an open box
Fig. 2. MV infection of CD11c+ DCs from CD11c-hSLAM tg mice in vitro
and in vivo. (A) In vitro MV infection of CD11c+ DCs from CD11c-
hSLAM tg mice. DCs enriched from splenocytes of non-tg or tg mice were
either mock-infected (filled histogram) or infected with MV-JWB (open
histogram) at 0.3 MOI. Two dpi, the expression of MV glycoproteins on
CD11c+ DCs, was analyzed by flow cytometry. (B) In vivo infection of
CD11c-hSLAM tg mice. Adult animals of both tg mice and non-tg mice
were mock-infected (filled histogram) or injected intravenously with
MV-JWB (open histogram) at 2  106 TCID50. Four dpi, splenic CD11c+
DCs were analyzed for expression of MV proteins. Data shown represent
three independent experiments.
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(NK1.1+). A minimal level of hSLAM expression was
detected on CD11cCD11b+ macrophages. Because boneFig. 3. Alteration of DCs from CD11c-hSLAM tg mice by MV infection. (A) MV i
(filled histogram) or MV-infected (open histogram) and stained with Annexin Vand
for Annexin V positivity. Apoptotic cells are represented in each graph. (B) M
Splenocytes from hSLAM tg mice were mock-infected or MV-infected. At 2 dpi,
class I, or anti-MHC class II antibodies. The geometric mean fluorescence intensi
independent experiments.marrow BM cells contain DC progenitors and have been
widely used to generate CD11c+ DCs in the presence of the
cytokine GM-CSF, we generated BM-derived CD11c+ DCs
from hSLAM tg mice and investigated for their expression
of hSLAM protein. Over time, as shown in Fig. 1C, BM
cells in response to GM-CSF yielded equivalent numbers of
CD11c+ DCs in hSLAM tg as compared to non-tg mice.
However, in BM-derived CD11c+ DCs from tg mice,
amounts of hSLAM protein increased over time (both
CD11c+ and hSLAM+ cells: d3: 23%, d6: 34%, d9: 52%)
whereas CD11c+ cells from non-tg mice did not (Fig. 1C).
These data indicate that hSLAM protein was expressed on
the surfaces of CD11c+ DCs obtained from splenocytes and
precursor BM stem cells.
MV infects and alters DCs from CD11c-hSLAM tg mice
To determine whether hSLAM expression on mouse
CD11c+ DCs rendered them susceptible to MV infection,
DCs were enriched from splenocytes of tg or non-tg mice and
then infected in vitro with wt JW strain of MVat 0.3 MOI. At
2 dpi, the expression of viral proteins on CD11c+ DCs was
assessed by flow cytometry (Hahm et al., 2003). About 35%
of CD11c+ DCs from CD11c-hSLAM tg mice were infected
with MV and expressed viral proteins on their surfaces. In
contrast, fewer than 6% of CD11c+ DCs from non-tg mice
scored positive for MV proteins after incubation with MV
(Fig. 2A). The low level of expression ofMVproteins onDCs
from non-hSLAM tg mice incubated with MV likely resulted
from either nonreceptor-specific binding of MV to mouse
DCs or from the intrinsic phagocytic ability of DCs, because
nonreplicating, UV-inactivated MV induced an equivalent
level of viral glycoprotein expression on similar numbersnfection induces apoptosis of splenic DCs. Splenocytes were mock-infected
7-AAD at 1 and 2 dpi. Living DCs (CD11c+ 7-AAD cells) were analyzed
V infection downregulated expression of DC markers on splenic DCs.
CD11c+ DCs were stained with anti-CD40, anti-B7-1, anti-B7-2, anti-MHC
ty (MFI) for each marker is depicted on graphs. Data shown represent three
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MV infectivity was observed for other cell types of CD4+ and
CD8+ T cells, B cells, and CD11b+ cells between tg and non-
tg mice inoculated with MV. In addition, infectious viruses
were produced from in vitro infected DCs of tg mice as
detected by cocultivation assay when MV-infected DCs
cocultured with B95-8 cells and cytopathic effects and
syncytia formation observed on B95-8 cells (unpublished
data). When tg and non-tg mice were infected intravenously
with MV in vivo, 2–5% of splenic DCs from tg mice
expressed viral proteins, although <1% of DCs from non-tg
mice were positive for MV proteins (Fig. 2B). In vivo, MV
infectivity was consistently observed in several independent
experiments. However, because 2–5% of CD11c+ DCs were
infected in vivo compared to >35% of CD11c+ DCs in vitro,
we focused our next series of experiments on the in vitro
infection model.
Human DCs undergo apoptosis during MV infection
(Fugier-Vivier et al., 1997; Servet-Delprat et al., 2000a).
However, because human DCs express both CD46 and also
SLAM receptor, it is not known if both or only one of these
receptors is responsible. Therefore, MV-infected spleno-
cytes from tg mice were stained for CD11c, Annexin V as
an early marker of apoptosis, and 7-AAD to exclude dead
cells, and analyzed hereafter by flow cytometry. As shown
in Fig. 3A, 29% of splenic CD11c+ DCs from tg mice were
undergoing apoptosis within 1 day after MV infection,
whereas only 9% of mock-infected control cells were
Annexin V-positive. By 2 dpi, 52% of MV-incubated
splenic DCs scored positive for apoptosis but only 18% of
mock-infected cells were positive. BM-derived CD11c+Fig. 4. Inhibition of mitogen-dependent T-cell proliferation by MV-infected DCs fro
for 10 days with GM-CSF were mock-infected (dotted line) or infected with MV
CFSE-labeled lymphocytes in the presence of PMA and ionomycin. The CD4+ an
CD25, and CD69 by flow cytometry. Left histograms show the baseline CFSE-lab
line: T cells with MV-infected DCs, or dotted line: T cells with mock-infected DDCs infected with MV also showed enhanced rate of
apoptosis (10–15% above the mock-infected BM-DCs)
(unpublished data). Thus, hSLAM expression alone on
mouse DCs rendered them permissive to MV infection
and resulted in programmed cell death.
We next examined the expression of several important
DC surface proteins on splenic CD11c+ DCs after MV
infection. Costimulatory molecules B7-1, B7-2, and CD40
and MHC class I and II proteins on the surfaces of CD11c+
DCs were all downregulated following MV infection (Fig.
3B). When non-tg DCs were treated with MV, the expres-
sion of costimulatory molecules and MHC molecules on
their surfaces hardly changed compared to their expression
on mock-infected non-tg DCs (unpublished data). Further,
MV infection of tg DCs as detected by MV protein
expression closely correlated with the reduction in surface
expression of these molecules (unpublished data). Because
these proteins are known to play a decisive role in DC-
induced generation of adaptive T-cell responses, we next
evaluated the ability of MV-infected DCs to activate and
expand naive T cells.
MV-infected DCs inhibit syngeneic and allogeneic T-cell
proliferation
DCs expressing hSLAM were either mock-infected or
MV-infected and, at 3 dpi, were UV-irradiated to block
trans-infection of T cells. Then, CFSE-labeled syngeneic T
lymphocytes from mice engineered to express hSLAM only
on those cells through use of an Lck promoter (Hahm et al.,
2003) were added to the culture along with PMA andm CD11c-hSLAM tg mice. CD11c+ DCs derived from tg BM cells cultured
-JWB (solid line). Three dpi, they were UV-irradiated and then mixed with
d CD8+ T cells were analyzed for proliferation and the expression of CD44,
eled cells at day 0 (d0, filled histogram) and proliferation at day 4 (d4, solid
Cs).
Fig. 5. Impairment of allostimulatory capacity of DCs expressing hSLAM by MV infection. Panel (A) shows the inhibition of allogeneic T-cell proliferation by
MV infection of DCs in a MLR. BM-derived DCs from CD11c-hSLAM tg mice of FVB/N (H-2q) strain were mock-infected or MV-infected. Three dpi, they
were cocultured with CFSE-labeled T lymphocytes from C57BL/6 (H-2b). Histograms show the baseline CFSE-labeled at day 0 (d0; filled histogram) and
proliferation at days 2 or 4. Dotted lines represent the proliferation of CD8+ T cells primed by mock-infected DCs, and solid lines show their impaired
proliferation when in contact with MV-infected DCs. (B) Inhibition of T-cell activation by MV-infected DCs in an allogeneic MLR. At day 4 after coculture of
T cells with mock-infected DCs (dotted line) or with MV-infected DCs (solid line), the level of CFSE fluorescence and CD44, CD25, and CD69 expression on
the CD8+ T cells was assessed by flow cytometry.
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T lymphocytes proliferated normally when incubated with
either mock-infected DCs from CD11c-hSLAM tg mice
(Fig. 4) or DCs from non-tg mice inoculated with MV
(Fig. 6). In contrast, MV infected, hSLAM+ CD11c+ DCs
from tg mice greatly inhibited T-cell proliferation (Fig. 4).Fig. 6. hSLAM expression on T cells is not required for the inhibition of T-cell pr
mice or non-tg mice were mock-infected or MV-infected. They were cocultured w
mitogenic stimulus. Filled histogram is basal level of CFSE at day 0 of coculture. D
4 with a culture of mock-infected DCs and MV-infected DCs, respectively.Although T cells exhibited significantly reduced prolifera-
tion in response to mitogens in the presence of MV-infected
CD11c+ DCs, the phenotypic expression of CD44, CD25,
and CD69 was not blocked.
Now we addressed the question whether MV-infected
hSLAM+ CD11c+ DCs could generate an MLR. Asoliferation by MV-infected DCs. BM-derived DCs from CD11c-hSLAM tg
ith CFSE-stained T cells from Lck-hSLAM tg mice or non-tg mice under
otted lines and solid lines represent the proliferation of CD4+ T cells at day
Fig. 7. IFN-a/h-R, TNF-a, LT-a, or LT-h from T cells are not essential components for the inhibition of T-cell proliferation by MV-infected DCs. BM-derived
DCs from CD11c-hSLAM tg mice were mock-infected or MV-infected as in Fig. 6. CFSE-stained T cells from ko mice deficient in IFN-a/h-R, TNF-a, LT-a,
or LT-h were cocultured with mock-infected DCs (dotted line) or MV-infected DCs (solid line) with mitogenic stimulus. The proliferation of CD4+ T cells was
traced and shown at days 0 (filled histogram), 2, and 4.
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DCs from FVB/N mice (H-2q) and naive T cells from
C57BL/6 (H-2b), T cells rapidly proliferated at 2 and 4
days. In contrast, MV-infected hSLAM+ CD11c+ DCs lost
their ability to stimulate allogeneic T cells (Fig. 5A).
Analysis of CD8+ T cells showed that they were not or
were poorly activated, as judged by their low expression
levels of CD44, CD25, and CD69 molecules (Fig. 5B), and
by their inability to proliferate.
No role for hSLAM, IFN-a/b-R, TNF-a, LT-a, and LT-b from
T cells in the MV-induced CD11c+ DC-mediated inhibition
of T-cell proliferation
Lastly, we evaluated whether hSLAM, IFN-a/h-R,
TNF-a, LT-a, and LT-h from T cells played a role in
DC-mediated inhibition of T-cell proliferation subsequent
to MV infection because these molecules are thought
involved in lymphocyte proliferation or survival. First, to
test the possibility that MV glycoproteins interacted with
hSLAM on T cells thereby sending negative signal to T
cells that inhibited T-cell proliferation, we mixed various
combinations of either hSLAM+ CD11c+ DCs or
hSLAMCD11c+ DCs with or without MV and added
either hSLAM+ or hSLAM T cells. As anticipated,
mock-infected or MV-incubated hSLAM DCs did not
inhibit the proliferation of hSLAM(+ or ) T cells because
DCs were not infected (Fig. 6). In contrast, hSLAM+ DCs
infected with MV significantly impaired proliferation of T
lymphocytes either devoid of or bearing hSLAM (Fig. 6).
Therefore, the expression of hSLAM on T cells was not
necessary for the inhibition of T-cell proliferation induced
by MV-infected DCs, including those from genetically
different knock-out (ko) mice that did not express hSLAMon their T cells. The last series of experiments showed that
T cells genetically deficient for IFN-a/h-R, TNF-a, LT-a,
or LT-h did not proliferate in response to mitogens in the
presence of MV-infected CD11c+ DCs (Fig. 7), indicating
that none of these T-cell molecules played an individual
role in MV-induced CD11c+ DC-mediated inhibition of T-
cell proliferation.Discussion
We report here that murine DCs expressing hSLAM
were obtained by generating tg mice expressing hSLAM,
an MV receptor, and that these DCs were now permissive
to wt MV infection. CD11c+ DCs isolated from the spleen
and BM of these tg mice expressed hSLAM and, when
infected with MV, lost the ability to function normally.
Such impaired MV-infected DCs did not support T-cell
proliferation.
Transgenic mice expressed the hSLAM protein under
control of a CD11c promoter, and the presence of this
protein on DCs conferred susceptibility to MV infection.
Human DCs express SLAM and CD46 and both molecules
act as receptors for MV. MV infection was previously
shown to induce maturation of human immature DCs
derived from blood CD34+ cells and monocytes (Schnorr
et al., 1997; Servet-Delprat et al., 2000b). It is likely that
phenotypic maturation of DCs helps immature DCs to
transport MV from its primary MV infection area of
infection to a secondary site, a lymphoid organ, where T
lymphocytes reside. However, MV-infected mouse mature
DCs in spleen were highly susceptible to apoptosis and
downregulated B7-1, B7-2, CD40, MHC class I, and MHC
class II molecules (Fig. 3), implying that MV-infected
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MV might exploit the DC network for travel to secondary
lymphoid organs by infecting immature DCs that are
induced to mature then migrate to these organs. In such
organs, subsequently DCs loaded with MV proteins inhibit
stimulation of naive T cells. Therefore, MV can likely
amplify itself in lymphocytes without being counteracted
by newly acquired anti-MV immune responses (Hyypia et
al., 1985; Joseph et al., 1975; McChesney et al., 1988;
Sullivan et al., 1975).
Failure to respond to recalled antigenic, mitogenic, and
allogeneic stimulation of T cells is a characteristic of MV
infection. Similarly, we observed here inhibition of T-cell
proliferation using MV-infected mouse CD11c+ DCs bear-
ing hSLAM receptor (Figs. 4 and 5). Without direct viral
infection of T cells, mitogen-dependent T-cell proliferation
was significantly inhibited by MV-infected DCs, which
might have occurred by contact of viral proteins from
MV-infected DCs with T cells (Dubois et al., 2001; Klagge
et al., 2000; Laine et al., 2003; Marie et al., 2001) or by yet
undiscovered soluble factors secreted by the cocultures (Sun
et al., 1998). Interestingly, the expression of T-cell activa-
tion markers (CD25, CD69, and CD44) was not impaired by
MV-infected DCs when mitogenic stimulus was given for T-
cell activation to directly trigger protein kinase C signaling
pathway (Fig. 4). However, when the stimulus was alloge-
neic, these molecules were poorly expressed on T cells (Fig.
5), indicating MHC class II-dependent allostimulatory ca-
pacity of DCs was severely impaired by MV infection. In
both cases, MV-infected DCs strongly inhibited T-cell
proliferation regardless of the surface expression level of
T-cell activation markers. On studying the defect in prolif-
eration, we found that individual expression of hSLAM,
type I IFN receptor, TNF-a, LT-a, or LT-h from T cells was
not essential for MV-induced CD11c+ DC-mediated inhibi-
tion of T-cell proliferation (Figs. 6 and 7).
Although hSLAM expression on T cells was not required
for MV-infected DC-mediated inhibition of T-cell prolifer-
ation, MV bound directly to hSLAM; therefore, this protein
may alter normal immune system function. SLAM has been
identified as the cellular target protein for several viruses
(Sidorenko and Clark, 2003). For example, Morvilliviruses
such as rinderpest virus, canine distemper virus, as well as
MV use SLAM as their receptor (Tatsuo et al., 2001), while
Molluscum contagiosum virus encodes proteins that are
homologous to SLAM (Bugert et al., 2000). Moreover,
individuals infected with HIV display altered expression
of SLAM on their T cells (Meroni et al., 1999). These
observations, in concert, imply that SLAM may play an
important role in regulating immune responses to pathogens
and is thus chosen by many viruses to subordinate the hosts
protective immune arsenal. Because MV downregulates
hSLAM on lymphocytes (Hahm et al., 2003; Tanaka et
al., 2002) and SLAM associates with SAP and Fyn tyrosine
kinase (Chan et al., 2003; Latour et al., 2003), the effect of
MV infection on SLAM-mediated signaling and immunemodulation promises to be an area of interest and impor-
tance. For this analysis, the tg mice expressing hSLAM
receptor separately but specifically on T cells and on DCs
should be useful tools. Both human and mouse SLAM
possess 100% identity of three tyrosine-based motifs within
their cytoplasmic region (Wang et al., 2001). This mediates
SLAM-SAP binding. Therefore, MV binding to human
SLAM may likely affect intracellular SLAM-SAP signaling
pathway in mouse cells.
In summary, our findings show that MV infection of
DCs restricted through the SLAM receptor disrupts DC
function by a multifacet strategy. First, the virus infects
CD11c+ DCs and inhibits their terminal maturation by
disordering MHC and costimulatory molecules necessary
for antigen presentation. Second, MV infection renders DCs
susceptible to apoptosis, which restricts quantitatively the
number of DCs capable of generating adaptive immune
responses. The events surrounding MV infection are likely
to shed knowledge not only on how MV induces immu-
nosuppression but may be mirrored, in part, by a variety of
other viruses such as HIV (Knight and Patterson, 1997),
lymphocytic choriomeningitis virus (Sevilla et al., 2003),
cytomegalovirus (Raftery et al., 2001), herpes simplex
virus (Kruse et al., 2000), dengue virus (Wu et al., 2000),
and other infectious agents who have also developed
strategies to avert or usurp the function of DCs for their
benefit.Materials and methods
Construction of expression plasmid
The hSLAM cDNAwas PCR-amplified by using pCAG-
SLAM, which was provided by Yusuke Yanagi (Kyushu
University), as a template in combination with the following
primers: 5V-CGGAATTCACCATGGATCCCAAGGGGC-
TCCT-3V and 5V-CGGAATTCCCTTCAGAAAGTCCCTT-
TGTTGG-3V. To construct pCD11c-hSLAM, amplified
hSLAM cDNA was digested with EcoRI and then cloned
into an EcoRI-treated pCD11c vector, which was obtained
from Dan R. Littman (New York University Medical Cen-
ter). The pCD11c vector contains CD11c promoter and a h-
globin expression cassette that has a transcription terminator
for efficient gene expression in tg mice (Brocker et al.,
1997). The entire hSLAM gene and the junction sites
between the vector and the inserted gene were sequenced
to ensure proper construction.
Generation of tg mice
The 7.7 kb transgene of CD11c promoter-hSLAM frag-
ment was isolated by digestion of pCD11c-hSLAM with
XhoI and NotI and was microinjected into either FVB/N or
FVB/N  C57BL/6 fertilized oocytes. The oocytes were
then implanted into pseudopregnant CD1 female mice at the
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pups, and DNA was isolated for detection of hSLAM
cDNA. Five FVB/N and one FVB/N  C57BL/6 tg mouse
founders were identified using a PCR assay as described
(Hahm et al., 2003).
Mice
Were maintained in the closed breeding colony of TSRI.
The origin, genotyping, and use of Lck-hSLAM tg mice
(Hahm et al., 2003), IFN-a/h-receptor (R) ko mice (Muller
et al., 1994), tumor necrosis factor (TNF)-a ko mice
(Korner et al., 1997), lymphotoxin (LT)-a ko mice (Fu et
al., 1997), and LT-h ko mice (Koni et al., 1997; Oldstone et
al., 2002) has been reported.
Culture of DCs
BM cells were isolated and cultured as described with
minor modifications (Lutz et al., 1999). BM cells obtained by
flushing femurs and tibias with a PBS solution were resus-
pended in 0.83% of ammonium chloride for 3 min to lyse red
blood cells. Then 3–4 million cells were cultured on a 100-
mm tissue culture plate with RPMI complete medium con-
taining 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin,
100 Ag/ml streptomycin, 10 mM HEPES, 1 mM sodium
pyruvate, 0.1 mM nonessential amino acids, 0.05 mM h-
mercaptoethanol, and 200 U/ml rmGM-CSF (Peprotech).
Every 2–3 days of culture, half of the medium was removed
and replaced by fresh rmGM-CSF-supplemented culture
medium. After 10 days of culture, nonadherent cells were
pooled by gentle pipetting and used as a source of BM-
derived DCs. From spleens of tg or non-tg littermates, DCs
were obtained after digestion with collagenase D (1 mg/ml,
type II, Sigma) at 37 jC for 15 min. To disrupt T-cell–DC
complexes, 0.01 M of EDTA was added and incubation
continued for 5 min. Single cells were then obtained by
mechanical disruption as described (Hahm et al., 2003).
When necessary, splenic DCs were enriched (50–70%) with
appropriate columns (Stem cell Technologies Inc.) and cul-
tured in complete medium containing rmGM-CSF.
Analysis of MV infection
Wt MV, JW strain, required several passages on B95-
8 cells (fewer than 10 times) to sufficiently enhance viral
titers for experimental study. This virus is referred to as MV-
JWB (Hahm et al., 2003;Manchester et al., 2000). B95-8 cells
were maintained in RPMI 1640 medium containing 7% FBS,
2 mM L-glutamine, 100 U/ml penicillin, and 100 Ag/ml
streptomycin. For MV-binding to DCs in vitro, BM-derived
DCs or splenic DCs from CD11c-hSLAM tg or non-tg mice
were incubated with either MV-free media as a negative
control (mock infection) or MV-JWB at 0.1–0.5 multiplicity
of infection (MOI) on ice for 2 h. After washing with PBS,
cells were cultured in complete media containing rmGM-CSF. For MV infection in vivo, 8- to 12-week-old tg or non-
tg mice were injected intravenously with MV-JWB at a dose
of 2  106 TCID50 in a volume of 250 Al. Mice were
sacrificed 3–4 days after inoculation and splenocytes har-
vested as above. For a negative control, MV-free cell super-
natants were prepared identically to JW virus stock and used
for mock in vivo infection analysis.
Flow cytometric analysis
Incubation of cells with various fluorochrome-conjugated
antibodies was carried out for 20 min on ice in PBS
containing 1% FBS and 0.1% sodium azide. After washing
three times, cells were fixed in 1% formaldehyde in PBS.
Antibodies used in this study were specific for murine CD4,
CD8, B220, CD11b, CD11c, NK1.1, CD44, CD25, CD69,
H-2Kq MHC class I, I-A/I-E MHC class II, CD40, B7-1, and
B7-2 antibodies (BD PharMingen). Staining for hSLAMwas
performed with an anti-hSLAM antibody (Advanced Immu-
noChemical Inc.) conjugated to Cy5 using a monoclonal
antibody labeling kit (Amersham Biosciences). For the
detection of surface MV proteins, cells were incubated with
a human polyclonal serum to MV (Hahm et al., 2003) for 20
min, washed 3 times, and then stained with FITC or PE-
conjugated donkey anti-human IgG antibody (Jackson
Immunoresearch Laboratories). Fluorescent cells were ac-
quired with a FACSCalibur flow cytometer (Becton Dick-
inson) then analyzed with FlowJo (Treestar) software.
Proliferation assay
To examine the effect of MV-infected DCs on T-cell
proliferation, BM-derived CD11c+ DCs from tg or non-tg
mice of the FVB/N strain (H-2q) were either mock-infected
or MV-infected and then UV-irradiated at 3 days post-
infection (dpi) to block trans-infection of T cells. MV-
infected DCs on 24-well plates were UV-irradiated by 30
min of exposure with a 254-nm UV lamp. This treatment
inactivated infectious virus as no infected T cells were
observed by FACS analysis in the coculture experiment.
Lymphocytes obtained from various Lck-hSLAM tg, non-
tg, or ko mice were labeled with carboxyfluorescein
succidimyl ester (CFSE; Molecular Probes, Eugene, OR)
as described (Hahm et al., 2003), mixed with DCs, treated
with 20 ng/ml PMA, and 1 Ag/ml ionomycin, and cultured
in complete medium containing 50 U/ml of IL-2. For
MLR, splenic T cells of C57BL/6 strain (H-2b) were used
in the coculture with mock-infected DCs or MV-infected
DCs from CD11c-hSLAM tg mice. The level of CFSE
fluorescence from T cells was traced by flow cytometric
analysis.
Apoptotic analysis
Splenocytes obtained from CD11c-hSLAM tg mice were
either mock-infected or infected with MV and cultured with
B. Hahm et al. / Virology 323 (2004) 292–302300complete media containing GM-CSF. At day 1 and 2 post-
infection, cells were stained for surface antigen (CD11c-
allophycocyanin conjugated), washed, and subsequently
incubated for 15 min with Annexin V-FITC and 7-amino-
actinomycin D (7-AAD) according to the manufacturer’s
recommendations (Pharmingen). After staining, cells were
immediately acquired and analyzed.Acknowledgments
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